These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23991916)

  • 1. Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study.
    Schjelderup P; Dahle DO; Holdaas H; Mjøen G; Nordby G; Abedini S; Jardine A; Fellström B; Svensson M
    Clin Transplant; 2013; 27(6):E636-43. PubMed ID: 23991916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients.
    Dahle DO; Jenssen T; Holdaas H; Leivestad T; Vårdal M; Mjøen G; Reisaeter AV; Toft I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):134-40. PubMed ID: 24372653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes.
    Huang Z; Song T; Fu L; Rao Z; Zeng D; Qiu Y; Wang X; Xie L; Wei Q; Wang L; Lin T
    Int Urol Nephrol; 2015 Sep; 47(9):1577-85. PubMed ID: 26246037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.
    Bleskestad IH; Bergrem H; Leivestad T; Hartmann A; Gøransson LG
    Clin Transplant; 2014 Apr; 28(4):479-86. PubMed ID: 25649861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
    Pihlstrøm H; Dahle DO; Mjøen G; Pilz S; März W; Abedini S; Holme I; Fellström B; Jardine AG; Holdaas H
    Transplantation; 2015 Feb; 99(2):351-9. PubMed ID: 25594550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
    Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
    Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset anemia after kidney transplantation is an independent factor for graft loss: a multicenter, observational cohort study.
    Pascual J; Jiménez C; Franco A; Gil M; Obrador-Mulet AR; Gentil MA; Romero R; Grinyó JM; Hernández D; Morales JM; Pallardó LM; Serón D; Arias M; Campistol JM;
    Transplantation; 2013 Oct; 96(8):717-25. PubMed ID: 23896555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality after kidney transplant failure: the impact of non-immunologic factors.
    Gill JS; Abichandani R; Kausz AT; Pereira BJ
    Kidney Int; 2002 Nov; 62(5):1875-83. PubMed ID: 12371992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trend from cardiovascular to non-cardiovascular late mortality in patients with renal replacement therapy since childhood.
    Vogelzang JL; van Stralen KJ; Jager KJ; Groothoff JW
    Nephrol Dial Transplant; 2013 Aug; 28(8):2082-9. PubMed ID: 23468535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pretransplant dialysis modality on renal allograft outcome.
    Schwenger V; Döhler B; Morath C; Zeier M; Opelz G
    Nephrol Dial Transplant; 2011 Nov; 26(11):3761-6. PubMed ID: 21427080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of renal transplantation in recipients with Wegener's granulomatosis.
    Shen J; Gill J; Shangguan M; Sampaio MS; Bunnapradist S
    Clin Transplant; 2011; 25(3):380-7. PubMed ID: 20394635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of anemia on patient and graft survival after renal transplantation: results from the French DIVAT cohort.
    Garrigue V; Szwarc I; Giral M; Soulillou JP; Legendre C; Kreis H; Kessler M; Ladrière M; Kamar N; Rostaing L; Morelon E; Buron F; Daguin P; Mourad G
    Transplantation; 2014 Jan; 97(2):168-75. PubMed ID: 24162254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
    Drechsler C; Pihlstrøm H; Meinitzer A; Pilz S; Tomaschitz A; Abedini S; Fellstrom B; Jardine AG; Wanner C; März W; Holdaas H
    Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death.
    Aalten J; Hoogeveen EK; Roodnat JI; Weimar W; Borm GF; de Fijter JW; Hoitsma AJ
    Transpl Int; 2008 Oct; 21(10):985-91. PubMed ID: 18564985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients.
    Hjelmesaeth J; Ueland T; Flyvbjerg A; Bollerslev J; Leivestad T; Jenssen T; Hansen TK; Thiel S; Sagedal S; Røislien J; Hartmann A
    J Am Soc Nephrol; 2006 Jun; 17(6):1746-54. PubMed ID: 16687626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes.
    Marcén R; Galeano C; Fernandez-Rodriguez A; Jiménez S; Teruel JL; Burgos FJ; Quereda C
    Transplant Proc; 2012 Nov; 44(9):2593-5. PubMed ID: 23146465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation.
    Taber DJ; Meadows HB; Pilch NA; Chavin KD; Baliga PK; Egede LE
    Clin Transplant; 2013; 27(2):274-82. PubMed ID: 23383719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.